Literature DB >> 22930798

Retraction. "Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium)" (J Clin Pathol 2009;62:128–38;doi:10.1136/jcp.2008.057257).

.   

Abstract

The Journal of Clinical Pathology wishes to inform its readers of the authors' retraction of the following article for redundancy. The original article by D de Jong, W Xie, Rosenwald, M Chhanabhai, P Gaulard,W Klapper, A Lee, B Sander, C Thorns,E Campo, T Molina, A Hagenbeek,S Horning, A Lister, J Raemaekers, G Salles, R D Gascoyne and E Weller entitled "Immunohistochemical prognostic markersi n diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium)" (J Clin Pathol 2009;62:128–38;doi:10.1136/jcp.2008.057257) published online on 15 September 2008, contained substantial overlap in text, data, and conclusions compared with a previous article with the same title published in Journal of Clinical Oncology on 1 March 2007 by Daphne de Jong, Andreas Rosenwald, Mukesh Chhanabhai, Philippe Gaulard,Wolfram Klapper, Abigail Lee, Birgitta Sander, Christoph Thorns, Elias Campo, Thierry Molina, Andrew Norton, Anton Hagenbeek, Sandra Horning, Andrew Lister, John Raemaekers, Randy D Gascoyne, Gilles Salles and Edie Weller (doi:10.1200/JCO.2006.09.4490). In addition, the authors did not cite the Journal of Clinical Oncology article in the paper published in Journal of Clinical Pathology.

Entities:  

Year:  2012        PMID: 22930798     DOI: 10.1136/jcp.2008.057257ret

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  1 in total

1.  The expression of hepatoma-derived growth factor in primary central nervous system lymphoma and its correlation with angiogenesis, proliferation and clinical outcome.

Authors:  San-Zhong Li; Yong-Bo Zhao; Wei-Dong Cao; Yan Qu; Peng Luo; Hai-Ning Zhen; Xiao-Yan Chen; Zhi-Feng Yan; Zhou Fei
Journal:  Med Oncol       Date:  2013-06-15       Impact factor: 3.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.